Single-cell and spatial RNA sequencing in prostate cancer

Area of Science:

• Prostate biology and cancer research.

Background:

• Single-cell RNA sequencing (scRNA-seq) is crucial for understanding prostate organ development, disease initiation, and progression.
• scRNA-seq provides insights into benign prostatic hyperplasia and metastatic prostate cancer, focusing on the tumor microenvironment, cellular plasticity, and therapy resistance.

Purpose of the Study:

• To explore the application of scRNA-seq and spatial transcriptomics in prostate cancer research.
• To investigate cellular interactions, heterogeneity, and genomic alterations in prostate cancer.

Main Methods:

• Utilizing single-cell RNA sequencing (scRNA-seq) to analyze cellular composition and interactions.
• Employing spatial transcriptomics for high-resolution analysis of tumor architecture.
• Integrating genomic and transcriptomic data for clonal evolution and therapy resistance analysis.

Main Results:

• scRNA-seq identified complex interactions between epithelial, stromal, and immune cells driving disease heterogeneity.
• Spatial transcriptomics enabled characterization of tumor architecture at single-cell resolution.
• Bioinformatic inference of copy number variants facilitated integrated genomic-transcriptomic analysis.

Conclusions:

• Understanding prostate cancer heterogeneity through these advanced techniques can support patient stratification.
• Biomarker development and novel therapeutic strategies targeting genomic instability and tumor microenvironment interactions are potential outcomes.
• These technologies offer a comprehensive view of prostate cancer biology, paving the way for personalized medicine.